Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.

Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.

View in: PubMed

subject areas

Abatacept
Adenoviridae
Animals
Antigens, CD
Antigens, Differentiation
Apoptosis
Cell Differentiation
Cell Movement
Cells, Cultured
Coculture Techniques
CTLA-4 Antigen
Cytokines
Dendritic Cells
Drug Combinations
Gene Expression Regulation
Genetic Vectors
Graft Enhancement, Immunologic
Graft Survival
Green Fluorescent Proteins
Growth Inhibitors
Heart Transplantation
Immunoconjugates
Immunosuppressive Agents
Lipopolysaccharides
Luminescent Proteins
Lymphocyte Activation
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Inbred C57BL
NF-kappa B
Oligodeoxyribonucleotides
Protein Engineering
Th1 Cells
Th2 Cells
Tissue Donors
T-Lymphocytes
Transgenes

authors with profiles

John Fung